{"id":98380,"date":"2025-09-03T15:50:06","date_gmt":"2025-09-03T15:50:06","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/"},"modified":"2025-09-03T15:50:06","modified_gmt":"2025-09-03T15:50:06","slug":"invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/","title":{"rendered":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&#038;A webcast and conference call"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p>Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the\u00a0<a href=\"https:\/\/www.idorsia.com\/investors\/news-and-events\/investor-webcasts\/aprocitentan-treatment-landscape\" rel=\"nofollow\" target=\"_blank\" title=\"OnDemand investor webcast\">OnDemand investor webcast<\/a>\u00a0outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension.<\/p>\n<p>Date: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <b>Monday, September 8, 2025<\/b><\/p>\n<p>Time: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <b>16:00 CEST \/ 15:00 BST \/ 10:00 EDT<\/b><\/p>\n<p>The call will start with a short presentation by senior management followed by a Q&amp;A session.<\/p>\n<p><b>Live Webcast (audio + slides):<\/b><br \/>The live webcast can be accessed from the Idorsia website <a href=\"https:\/\/www.idorsia.com\/investors\/news-and-events\/investor-webcasts\/aprocitentan-live-qa\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/www.idorsia.com\/investors\/news-and-events\/investor-webcasts\/aprocitentan-live-qa<\/a>.<\/p>\n<p><b>Dia<\/b><b>l-in<\/b> <b>procedure for analysts (audio only):<\/b> <br \/>Members of the investment community who wish to ask questions are required to register in advance of the conference using the following link<b>:<\/b><br \/><a href=\"https:\/\/register-conf.media-server.com\/register\/BIea30fa533efa48b880d7dc1852237e1a\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/register-conf.media-server.com\/register\/BIea30fa533efa48b880d7dc1852237e1a<\/a><\/p>\n<p><b>Replay:<\/b> A replay of the investor webcast will be available approximately 60 minutes after the call has ended.<\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the\u00a0OnDemand investor webcast\u00a0outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Monday, September 8, 2025 Time: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 16:00 CEST \/ 15:00 BST \/ [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":98381,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/bb724119-468d-4b1d-8206-3c2175d07f2b","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-98380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Gias Ul Hassan\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&amp;A webcast and conference call\" \/>\n\t\t<meta property=\"og:description\" content=\"Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-09-03T15:50:06+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-09-03T15:50:06+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&amp;A webcast and conference call\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#blogposting\",\"name\":\"Invitation to Idorsia\\u2019s aprocitentan (TRYVIO\\\/JERAYGO) investor Q&A webcast and conference call\",\"headline\":\"Invitation to Idorsia\\u2019s aprocitentan (TRYVIO\\\/JERAYGO) investor Q&#038;A webcast and conference call\",\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/bb724119-468d-4b1d-8206-3c2175d07f2b\"},\"datePublished\":\"2025-09-03T15:50:06+00:00\",\"dateModified\":\"2025-09-03T15:50:06+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#webpage\"},\"articleSection\":\"GlobeNewswire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"position\":2,\"name\":\"GlobeNewswire\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#listItem\",\"name\":\"Invitation to Idorsia\\u2019s aprocitentan (TRYVIO\\\/JERAYGO) investor Q&#038;A webcast and conference call\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#listItem\",\"position\":3,\"name\":\"Invitation to Idorsia\\u2019s aprocitentan (TRYVIO\\\/JERAYGO) investor Q&#038;A webcast and conference call\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Pakistan-News.png\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#organizationLogo\",\"width\":191,\"height\":78,\"caption\":\"Pakistan-News\"},\"image\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/\",\"name\":\"Gias Ul Hassan\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#webpage\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/\",\"name\":\"Invitation to Idorsia\\u2019s aprocitentan (TRYVIO\\\/JERAYGO) investor Q&A webcast and conference call\",\"description\":\"Idorsia will host a live investor Q&A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\\u2122 (aprocitentan) \\u2013 the first and only hypertension therapy targeting the endothelin pathway \\u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \\\/ 15:00 BST \\\/\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/bb724119-468d-4b1d-8206-3c2175d07f2b\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#mainImage\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\\\/#mainImage\"},\"datePublished\":\"2025-09-03T15:50:06+00:00\",\"dateModified\":\"2025-09-03T15:50:06+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&A webcast and conference call","description":"Idorsia will host a live investor Q&A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/","canonical_url":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#blogposting","name":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&A webcast and conference call","headline":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&#038;A webcast and conference call","author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/bb724119-468d-4b1d-8206-3c2175d07f2b"},"datePublished":"2025-09-03T15:50:06+00:00","dateModified":"2025-09-03T15:50:06+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#webpage"},"isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#webpage"},"articleSection":"GlobeNewswire"},{"@type":"BreadcrumbList","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news#listItem","position":1,"name":"Home","item":"https:\/\/pakistaninewspaperlist.com\/news","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","position":2,"name":"GlobeNewswire","item":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#listItem","name":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&#038;A webcast and conference call"},"previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#listItem","position":3,"name":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&#038;A webcast and conference call","previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}}]},{"@type":"Organization","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","url":"https:\/\/pakistaninewspaperlist.com\/news\/","logo":{"@type":"ImageObject","url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#organizationLogo","width":191,"height":78,"caption":"Pakistan-News"},"image":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author","url":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/","name":"Gias Ul Hassan"},{"@type":"WebPage","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#webpage","url":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/","name":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&A webcast and conference call","description":"Idorsia will host a live investor Q&A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website"},"breadcrumb":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#breadcrumblist"},"author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"creator":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/bb724119-468d-4b1d-8206-3c2175d07f2b","@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#mainImage"},"primaryImageOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/#mainImage"},"datePublished":"2025-09-03T15:50:06+00:00","dateModified":"2025-09-03T15:50:06+00:00"},{"@type":"WebSite","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website","url":"https:\/\/pakistaninewspaperlist.com\/news\/","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","inLanguage":"en-US","publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"}}]},"og:locale":"en_US","og:site_name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","og:type":"article","og:title":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&amp;A webcast and conference call","og:description":"Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/","og:url":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/","og:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","og:image:secure_url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","article:published_time":"2025-09-03T15:50:06+00:00","article:modified_time":"2025-09-03T15:50:06+00:00","twitter:card":"summary_large_image","twitter:title":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&amp;A webcast and conference call","twitter:description":"Idorsia will host a live investor Q&amp;A webcast and conference call following the publication of the OnDemand investor webcast outlining how TRYVIO\u2122 (aprocitentan) \u2013 the first and only hypertension therapy targeting the endothelin pathway \u2013 fits into the treatment landscape for difficult-to-control hypertension. Date: Monday, September 8, 2025 Time: 16:00 CEST \/ 15:00 BST \/","twitter:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png"},"aioseo_meta_data":{"post_id":"98380","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-09-03 16:05:04","updated":"2025-09-03 16:05:04","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/\" title=\"GlobeNewswire\">GlobeNewswire<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tInvitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&amp;A webcast and conference call\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/pakistaninewspaperlist.com\/news"},{"label":"GlobeNewswire","link":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/"},{"label":"Invitation to Idorsia\u2019s aprocitentan (TRYVIO\/JERAYGO) investor Q&#038;A webcast and conference call","link":"https:\/\/pakistaninewspaperlist.com\/news\/invitation-to-idorsias-aprocitentan-tryvio-jeraygo-investor-qa-webcast-and-conference-call\/"}],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/98380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=98380"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/98380\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/98381"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=98380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=98380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=98380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}